ICMCC

IBM and Cancer Institute of New Jersey want to use GRID technology to better predict outcome of cancer medication, fine tune therapy and develop new drugs.

Article (German)
Heise Online, 27 January 2008

28 January 2008 | Categories: News | Tag(s): GRID, Oncology
You can leave a response, or trackback from your own site.
If you appreciate our news pages, don't forget to subscribe or try the NEW ICMCC toolbar!